US Patent 7598257 | US Patents | Expiry | Expiration | Dates | PharmaCompass.com

Please Wait

Applying Filters...

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
NEW Find Prospects
- Prospector
Drugs in Dev.
News
Blog
Market Place
Login

Incyte Corporation

Trusted Global CDMO Partner Delivering End-to-End Pharma Manufacturing & Development Solutions.

Contact Supplier

Evonik Health Care is the innovation hub for leading life science companies

Contact Supplier

Aarti Pharmalabs is a partner of choice for pharmaceutical companies for APIs & Intermediates. Largest Indian producer of Caffeine.

Contact Supplier

Axplora is your partner of choice for complex APIs.

Contact Supplier

Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

Contact Supplier

pharmacompass-2-2026-02-09

Incyte Corporation

VIRTUAL BOOTH, Contact Details

VIRTUAL BOOTH
CONTACT DETAILS
Google Map, LinkedIn, Emails...

EVENTS

Webinars & Exhibitions

Webinars & Exhibitions

DIGITAL CONTENT

Interview #SpeakPharma, Vlog #PharmaReel, Data Compilation #PharmaFlow, 592 News #PharmaBuzz

Interview #SpeakPharma
Vlog #PharmaReel
Data Compilation #PharmaFlow
592 News #PharmaBuzz

DEVELOPMENTS

516 Drugs in Development

516 Drugs in Development

FINISHED DOSAGE FORMULATIONS

60 FDF Dossiers, 11 FDA Orange Book, 43 Europe, 6 Canada

60 FDF Dossiers
11 FDA Orange Book
43 Europe
6 Canada

INSPECTIONS & REGISTRATIONS

9 FDA

9 FDA

Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

11 All

01 11INCYTE CORP

filter Patent Number Reset all filters

11 All

01 117598257

filter API Patent Reset all filters

11 All

01 11Y

filter FDF Patent Reset all filters

11 All

01 11Y

filter Expiration Date Reset all filters

11 All

01 112027-12-24

01

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202192

Patent Use Code : U-3228

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202192

Patent Use Code : U-3227

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202192

Patent Use Code : U-3227

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

04

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202192

Patent Use Code : U-3228

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

05

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202192

Patent Use Code : U-3228

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

06

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202192

Patent Use Code : U-3227

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

07

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202192

Patent Use Code : U-3228

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

08

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202192

Patent Use Code : U-3228

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

09

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 202192

Patent Use Code : U-3227

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

10

INCYTE CORP

RUXOLITINIB PHOSPHATE

BePharma

Not Confirmed

INCYTE CORP

BePharma

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Patent Expiration Date : 2027-12-24

RUXOLITINIB PHOSPHATE

US Patent Number : 7598257

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 215309

Patent Use Code :

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2027-12-24

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

1
2

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.